One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1016/s1470-2045(21)00584-2
Copy DOI Journal: The Lancet. Oncology |  Publication Date: Dec 1, 2021 |
 Citations: 50 |
Affiliation: Samsung Medical Center, Sungkyunkwan University, University of Colorado Denver, University of Colorado Cancer Center, Seoul National University Bundang Hospital, South Texas Accelerated Research Therapeutics, Start Treatment & Recovery Centers, Massachusetts General Hospital, Seoul National University, Yonsei University, International Drug Development Institute (Belgium), The University of Texas at Austin, University of Washington, Yale Cancer CenterEvorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
